Materials • Major Chemicals
$28.52 ▼ -0.04
(-0.14%)
MKT CAP: $4.67B • VOL: 823.1K
52W L $20 52W H $38
PRM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $652.9M | $561.0M | $322.1M |
| YoY Revenue Growth % | +16.4% | +74.2% | — |
| Gross Profit | $375.1M | $317.1M | — |
| Gross Margin % | 57.5% | 56.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$200.9M | -$3.8M | $94.5M |
| Operating Margin % | -30.8% | -0.7% | 29.3% |
| Net Income (GAAP) | -$206.4M | -$5.9M | $67.5M |
| EBITDA (Normalized) | -$177.3M | $8.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $238.1M | $188.4M | $193.0K |
| Capital Expenditures (CapEx) | $29.6M | $15.5M | — |
| Free Cash Flow (FCF) | $208.6M | $172.9M | $193.0K |
| FCF Margin % | 31.9% | 30.8% | 0.1% |
| Return on Invested Capital (ROIC %) | -10.8% | -0.2% | — |
| Cash & Short-Term Equivalents | $325.9M | $198.5M | — |
| Total Debt (Short + Long Term) | $669.1M | $667.8M | — |
| Total Stockholders' Equity | $1.13B | $1.16B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PRM.